| Year |
Citation |
Score |
| 2024 |
Gandhi S, Sweeney HL, Hart CC, Han R, Perry CGR. Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response. Cells. 13. PMID 39056750 DOI: 10.3390/cells13141168 |
0.317 |
|
| 2024 |
Zhou Y, Zhang C, Xiao W, Herzog RW, Han R. Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice. Nature Communications. 15: 6141. PMID 39034316 DOI: 10.1038/s41467-024-50569-6 |
0.458 |
|
| 2024 |
Han R, Zhou Y, Zhang C, Xiao W, Herzog R. Systemic Delivery of Full-Length Dystrophin in DMD Mice. Research Square. PMID 38746161 DOI: 10.21203/rs.3.rs-3867299/v1 |
0.454 |
|
| 2023 |
Li H, Wang P, Zhang C, Zuo Y, Zhou Y, Han R. Defective BVES-mediated feedback control of cAMP in muscular dystrophy. Nature Communications. 14: 1785. PMID 36997581 DOI: 10.1038/s41467-023-37496-8 |
0.416 |
|
| 2022 |
Li H, Wang P, Hsu E, Pinckard KM, Stanford KI, Han R. Systemic AAV9.BVES Delivery Ameliorates Muscular Dystrophy in a Mouse Model of LGMDR25. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 36433649 DOI: 10.1016/j.ymthe.2022.11.012 |
0.429 |
|
| 2022 |
Li H, Zhang L, Zhang L, Han R. Autophagy in striated muscle diseases. Frontiers in Cardiovascular Medicine. 9: 1000067. PMID 36312227 DOI: 10.3389/fcvm.2022.1000067 |
0.401 |
|
| 2021 |
Zou X, Ouyang H, Pang D, Han R, Tang X. Pathological alterations in the gastrointestinal tract of a porcine model of DMD. Cell & Bioscience. 11: 131. PMID 34266495 DOI: 10.1186/s13578-021-00647-9 |
0.386 |
|
| 2020 |
Lau YS, Zhao L, Zhang C, Li H, Han R. Genetic disruption of the inflammasome adaptor ASC has minimal impact on the pathogenesis of Duchenne muscular dystrophy in mdx mice. Life Sciences. 118069. PMID 32659370 DOI: 10.1016/J.Lfs.2020.118069 |
0.468 |
|
| 2020 |
Zhang C, Li H, Han R. An open-source video tracking system for mouse locomotor activity analysis. Bmc Research Notes. 13: 48. PMID 32000855 DOI: 10.1186/S13104-020-4916-6 |
0.319 |
|
| 2019 |
Xu L, Lau YS, Gao Y, Li H, Han R. Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31129119 DOI: 10.1016/J.Ymthe.2019.05.001 |
0.376 |
|
| 2018 |
Lau YS, Xu L, Gao Y, Han R. Automated muscle histopathology analysis using CellProfiler. Skeletal Muscle. 8: 32. PMID 30336774 DOI: 10.1186/S13395-018-0178-6 |
0.487 |
|
| 2018 |
Xu L, Gao Y, Lau YS, Han R. Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice. Journal of Visualized Experiments : Jove. PMID 30124643 DOI: 10.3791/57560 |
0.334 |
|
| 2018 |
Sui T, Lau YS, Liu D, Liu T, Xu L, Gao Y, Lai L, Li Z, Han R. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9. Disease Models & Mechanisms. 11. PMID 29871865 DOI: 10.1242/Dmm.032201 |
0.439 |
|
| 2018 |
Sui T, Xu L, Lau YS, Liu D, Liu T, Gao Y, Lai L, Han R, Li Z. Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations. Cell Death & Disease. 9: 609. PMID 29789544 DOI: 10.1038/S41419-018-0674-Y |
0.446 |
|
| 2017 |
El Refaey M, Xu L, Gao Y, Canan BD, Adesanya TA, Warner SC, Akagi K, Symer DE, Mohler PJ, Ma J, Janssen PM, Han R. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice. Circulation Research. PMID 28790199 DOI: 10.1161/Circresaha.117.310996 |
0.446 |
|
| 2016 |
Xu L, Zhao L, Gao Y, Xu J, Han R. Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA. Nucleic Acids Research. PMID 27799472 DOI: 10.1093/Nar/Gkw1048 |
0.319 |
|
| 2016 |
Lin B, Govindan S, Sadayappan S, Zhao L, Xu J, Han R. ID: 77: FAST-SKELETAL MYOSIN BINDING PROTEIN-C REGULATES SKELETAL MUSCLE CALCIUM SENSITIVITY Journal of Investigative Medicine. 64: 917.1-917. DOI: 10.1136/Jim-2016-000120.13 |
0.504 |
|
| 2016 |
Refaey ME, Xu L, Xu J, Zhao L, Gao Y, Han R. 20. A Novel Approach in the Treatment of Dystrophic Cardiomyopathy Molecular Therapy. 24: S10. DOI: 10.1016/S1525-0016(16)32829-5 |
0.465 |
|
| 2015 |
Xu J, El Refaey M, Xu L, Zhao L, Gao Y, Floyd K, Karaze T, Janssen PM, Han R. Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy. Skeletal Muscle. 5: 43. PMID 26693275 DOI: 10.1186/S13395-015-0069-Z |
0.485 |
|
| 2015 |
Xu L, Park KH, Zhao L, Xu J, El Refaey M, Gao Y, Zhu H, Ma J, Han R. CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26449883 DOI: 10.1038/Mt.2015.192 |
0.541 |
|
| 2015 |
Zhao L, Xu L, Zhong Z, Zhai Y, Qiao L, Han R. Charged Vesicles Potently Induce NLRP3 Inflammasome Activation Biophysical Journal. 108: 423a. DOI: 10.1016/J.Bpj.2014.11.2315 |
0.471 |
|
| 2015 |
Xu L, Han R, Zhao L. Regulation of Myoblast Proliferation and Differentiation by Anoctamin 5 and 6 Biophysical Journal. 108: 423a. DOI: 10.1016/J.Bpj.2014.11.2314 |
0.41 |
|
| 2014 |
Cheng X, Zhang X, Gao Q, Ali Samie M, Azar M, Tsang WL, Dong L, Sahoo N, Li X, Zhuo Y, Garrity AG, Wang X, Ferrer M, Dowling J, Xu L, ... Han R, et al. The intracellular Ca²⺠channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy. Nature Medicine. 20: 1187-92. PMID 25216637 DOI: 10.1038/Nm.3611 |
0.507 |
|
| 2014 |
Zhao P, Torcaso A, Mariano A, Xu L, Mohsin S, Zhao L, Han R. Anoctamin 6 regulates C2C12 myoblast proliferation. Plos One. 9: e92749. PMID 24663380 DOI: 10.1371/Journal.Pone.0092749 |
0.414 |
|
| 2013 |
Lin B, Govindan S, Lee K, Zhao P, Han R, Runte KE, Craig R, Palmer BM, Sadayappan S. Cardiac myosin binding protein-C plays no regulatory role in skeletal muscle structure and function. Plos One. 8: e69671. PMID 23936073 DOI: 10.1371/Journal.Pone.0069671 |
0.472 |
|
| 2013 |
Xu L, Zhao P, Mariano A, Han R. Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases. Molecular Therapy. Nucleic Acids. 2: e112. PMID 23900226 DOI: 10.1038/Mtna.2013.39 |
0.409 |
|
| 2013 |
Mariano A, Henning A, Han R. Dysferlin-deficient muscular dystrophy and innate immune activation. The Febs Journal. 280: 4165-76. PMID 23527661 DOI: 10.1111/Febs.12261 |
0.403 |
|
| 2012 |
Han R, Zhao P, Xu L. Dysferlin is Dispensable for Recovering Saponin-Induced Membrnane Damage but Essential for Recovering Lengthening-Contraction-Induced Injury in mdx Mice Biophysical Journal. 102: 154a. DOI: 10.1016/J.Bpj.2011.11.842 |
0.572 |
|
| 2011 |
Han R, Rader EP, Levy JR, Bansal D, Campbell KP. Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice. Skeletal Muscle. 1: 35. PMID 22132688 DOI: 10.1186/2044-5040-1-35 |
0.71 |
|
| 2011 |
Xu L, Pallikkuth S, Hou Z, Mignery GA, Robia SL, Han R. Dysferlin forms a dimer mediated by the C2 domains and the transmembrane domain in vitro and in living cells. Plos One. 6: e27884. PMID 22110769 DOI: 10.1371/Journal.Pone.0027884 |
0.444 |
|
| 2011 |
Zhao P, Xu L, Ait-Mou Y, de Tombe PP, Han R. Equal force recovery in dysferlin-deficient and wild-type muscles following saponin exposure. Journal of Biomedicine & Biotechnology. 2011: 235216. PMID 21941430 DOI: 10.1155/2011/235216 |
0.536 |
|
| 2011 |
Han R. Muscle membrane repair and inflammatory attack in dysferlinopathy. Skeletal Muscle. 1: 10. PMID 21798087 DOI: 10.1186/2044-5040-1-10 |
0.48 |
|
| 2011 |
Campbell K, Han R, Kobuke K, Anderson M, Bernabé DBd, Kobayashi Y, Yang B. Improved genotyping of the dysferlin null mouse Protocol Exchange. DOI: 10.1038/Protex.2011.232 |
0.43 |
|
| 2011 |
Han R, Xu L, Pallikkuth S, Hou Z, Robia SL. Visualization of Dysferlin Self-Interaction Using Fluorescence Resonance Energy Transfer and Fluctuation Correlation Spectroscopy Biophysical Journal. 100: 346a. DOI: 10.1016/J.Bpj.2010.12.2091 |
0.504 |
|
| 2010 |
Han R, Frett EM, Levy JR, Rader EP, Lueck JD, Bansal D, Moore SA, Ng R, Beltrán-Valero de Bernabé D, Faulkner JA, Campbell KP. Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. The Journal of Clinical Investigation. 120: 4366-74. PMID 21060153 DOI: 10.1172/Jci42390 |
0.721 |
|
| 2009 |
Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, Michele DE, Muirhead DE, Kunz S, Moore SA, Iannaccone ST, Miyake K, McNeil PL, Mayer U, Oldstone MB, Faulkner JA, et al. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proceedings of the National Academy of Sciences of the United States of America. 106: 12573-9. PMID 19633189 DOI: 10.1073/Pnas.0906545106 |
0.693 |
|
| 2007 |
Han R, Campbell KP. Dysferlin and muscle membrane repair. Current Opinion in Cell Biology. 19: 409-16. PMID 17662592 DOI: 10.1016/J.Ceb.2007.07.001 |
0.554 |
|
| 2007 |
Han R, Bansal D, Miyake K, Muniz VP, Weiss RM, McNeil PL, Campbell KP. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. The Journal of Clinical Investigation. 117: 1805-13. PMID 17607357 DOI: 10.1172/Jci30848 |
0.649 |
|
| 2006 |
Han R, Bakker AJ. The effect of the PKC inhibitor calphostin C and the PKC agonist phorbol 12-myristate 13-acetate on regulation of cytosolic Ca(2+) in mammalian skeletal muscle cells. Toxicology and Applied Pharmacology. 212: 247-55. PMID 16150473 DOI: 10.1016/J.Taap.2005.07.023 |
0.384 |
|
| 2003 |
Han R, Suizu T, Grounds MD, Bakker AJ. Effect of indomethacin on force responses and sarcoplasmic reticulum function in skinned skeletal muscle fibers and cytosolic [Ca2+] in myotubes. American Journal of Physiology. Cell Physiology. 285: C881-90. PMID 12814911 DOI: 10.1152/Ajpcell.00063.2003 |
0.391 |
|
| 2003 |
Han R, Bakker AJ. The effect of chelerythrine on depolarization-induced force responses in skinned fast skeletal muscle fibres of the rat. British Journal of Pharmacology. 138: 417-26. PMID 12569066 DOI: 10.1038/Sj.Bjp.0705035 |
0.395 |
|
| Show low-probability matches. |